Advertisement
Loading...

Enhabit, Inc.

EHABNYSE
Healthcare
Medical - Care Facilities
$13.80
$0.01(0.07%)
U.S. Market is Open • 12:42
Advertisement

Enhabit, Inc. Fundamental Analysis

Enhabit, Inc. (EHAB) shows weak financial fundamentals with a PE ratio of -220.80, profit margin of -0.30%, and ROE of -0.58%. The company generates $1.1B in annual revenue with weak year-over-year growth of 2.44%.

Key Strengths

PEG Ratio-0.67
Current Ratio1.56

Areas of Concern

ROE-0.58%
Operating Margin7.25%
We analyze EHAB's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 23.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
23.1/100

We analyze EHAB's fundamental strength across five key dimensions:

Efficiency Score

Weak

EHAB struggles to generate sufficient returns from assets.

ROA > 10%
-0.27%

Valuation Score

Excellent

EHAB trades at attractive valuation levels.

PE < 25
-220.80
PEG Ratio < 2
-0.67

Growth Score

Moderate

EHAB shows steady but slowing expansion.

Revenue Growth > 5%
2.44%
EPS Growth > 10%
97.09%

Financial Health Score

Excellent

EHAB maintains a strong and stable balance sheet.

Debt/Equity < 1
0.87
Current Ratio > 1
1.56

Profitability Score

Weak

EHAB struggles to sustain strong margins.

ROE > 15%
-58.01%
Net Margin ≥ 15%
-0.30%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is EHAB Expensive or Cheap?

P/E Ratio

EHAB trades at -220.80 times earnings. This suggests potential undervaluation.

-220.80

PEG Ratio

When adjusting for growth, EHAB's PEG of -0.67 indicates potential undervaluation.

-0.67

Price to Book

The market values Enhabit, Inc. at 1.28 times its book value. This may indicate undervaluation.

1.28

EV/EBITDA

Enterprise value stands at 4.91 times EBITDA. This is generally considered low.

4.91

How Well Does EHAB Make Money?

Net Profit Margin

For every $100 in sales, Enhabit, Inc. keeps $-0.30 as profit after all expenses.

-0.30%

Operating Margin

Core operations generate 7.25 in profit for every $100 in revenue, before interest and taxes.

7.25%

ROE

Management delivers $-0.58 in profit for every $100 of shareholder equity.

-0.58%

ROA

Enhabit, Inc. generates $-0.27 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.27%

Following the Money - Real Cash Generation

Operating Cash Flow

Enhabit, Inc. generates limited operating cash flow of $88.04M, signaling weaker underlying cash strength.

$88.04M

Free Cash Flow

Enhabit, Inc. produces free cash flow of $80.94M, offering steady but limited capital for shareholder returns and expansion.

$80.94M

FCF Per Share

Each share generates $1.58 in free cash annually.

$1.58

FCF Yield

EHAB converts 11.44% of its market value into free cash.

11.44%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-220.80

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.67

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.28

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.66

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.87

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.56

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.01

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

0.07

vs 25 benchmark

How EHAB Stacks Against Its Sector Peers

MetricEHAB ValueSector AveragePerformance
P/E Ratio-220.8029.06 Better (Cheaper)
ROE-0.58%733.00% Weak
Net Margin-0.30%-53111.00% (disorted) Weak
Debt/Equity0.870.38 Weak (High Leverage)
Current Ratio1.564.02 Neutral
ROA-0.27%-19397.00% (disorted) Weak

EHAB outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Enhabit, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-92.45%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-100.47%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-78.20%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ